{"id":44965,"date":"2022-12-14T13:30:55","date_gmt":"2022-12-14T12:30:55","guid":{"rendered":"https:\/\/www.inovallee.com\/?p=44965"},"modified":"2022-12-15T14:47:28","modified_gmt":"2022-12-15T13:47:28","slug":"une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments","status":"publish","type":"post","link":"http:\/\/www.inovallee.com\/en\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/","title":{"rendered":"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments"},"content":{"rendered":"<p>Averoa est une <strong>startup biotech<\/strong> dont la sp\u00e9cialit\u00e9 est de d\u00e9velopper des solutions th\u00e9rapeutiques pour la prise en charge globale des <strong>maladies r\u00e9nales<\/strong>. Ses trois fondateurs, Caroline Roussel Maupetit, Sarah Delbaere et Luc-Andr\u00e9 Granier sont tous les trois riches de plus de 25 ans d\u2019exp\u00e9riences dans le domaine pharmaceutiques des maladies r\u00e9nales, et c\u2019est sur inovall\u00e9e, creuset de la medtech, qu\u2019ils ont choisi de d\u00e9velopper leur startup avec l\u2019aide du Tarmac.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Maladies r\u00e9nales, des pathologies trop tardivement d\u00e9tect\u00e9es<\/h3>\n\n\n\n<p>De nos jours, les pathologies r\u00e9nales chroniques sont d\u00e9tect\u00e9es tardivement car <strong>difficiles \u00e0 diagnostiquer<\/strong>, avec des traitements encore trop souvent invasifs. Averoa propose des <strong>solutions innovantes bas\u00e9es sur de nouveaux biomarqueurs <\/strong>et des m\u00e9canismes d\u2019actions non encore \u00e9tudi\u00e9s qui permettront un <strong>diagnostic pr\u00e9coce <\/strong>et par cons\u00e9quent une meilleure prise en charge th\u00e9rapeutique et un meilleur suivi des patients.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Le rein, un organe discret et pourtant essentiel<\/h3>\n\n\n\n<p>Cet organe assure la <strong>filtration du sang<\/strong> et l\u2019<strong>\u00e9vacuation<\/strong> via l\u2019urine des d\u00e9chets du corps. Il&nbsp;est aussi responsable de nombreux \u00e9l\u00e9ments essentiels \u00e0 la <strong>stabilit\u00e9 <\/strong>de notre organisme.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"756\" height=\"387\" src=\"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Rein-Fonctions.png\" alt=\"\" class=\"wp-image-44966\" srcset=\"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Rein-Fonctions.png 756w, https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Rein-Fonctions-300x154.png 300w\" sizes=\"(max-width: 756px) 100vw, 756px\" \/><\/figure>\n\n\n\n<p>On d\u00e9nombre principalement <strong>deux familles de pathologies&nbsp;:<\/strong><br>     1)&nbsp;<strong>Les maladies r\u00e9nales chroniques<\/strong>, et les complications qui en r\u00e9sultent comme l\u2019an\u00e9mie qui se traduit par une intense fatigue&nbsp;ou les d\u00e9sordres min\u00e9raux osseux qui entra\u00eenent des probl\u00e8mes cardiaques et des d\u00e9formations osseuses.<br>     2)&nbsp;<strong>Les maladies r\u00e9nales orphelines g\u00e9n\u00e9tiques<\/strong><br>Lorsqu\u2019ils ne fonctionnent plus correctement, les reins induisent des ph\u00e9nom\u00e8nes tr\u00e8s d\u00e9l\u00e9t\u00e8res mais souvent silencieux car agissant exclusivement sur des param\u00e8tres biologiques n\u2019entrainant pas de souffrance physique sauf cas particuliers (py\u00e9lon\u00e9phrite, colique n\u00e9phr\u00e9tique). De ce fait, les maladies r\u00e9nales sont <strong>le plus souvent sans sympt\u00f4mes cliniques pr\u00e9cis jusqu\u2019\u00e0 un stade tr\u00e8s avanc\u00e9.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Les maladies r\u00e9nales, enjeu de sant\u00e9 publique<\/h3>\n\n\n\n<p>Quelques chiffres sur les maladies r\u00e9nales&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>13,4% <\/strong>de la population europ\u00e9enne est atteinte de maladies r\u00e9nales chroniques.<\/li><li><strong>4 milliards<\/strong> d\u2019euros du budget annuel de la sant\u00e9 en France dont 82% pour les dialyses<\/li><li><strong>1 million <\/strong>d\u2019europ\u00e9ens sont actuellement sous dialyse ou en attente de greffe de reins<\/li><\/ul>\n\n\n\n<p>Ces chiffres pourraient \u00eatre drastiquement r\u00e9duits si la prise en charge des patients pouvait se faire plus t\u00f4t. En d\u2019autres termes, si le diagnostic \u00e9tait pr\u00e9coce. C\u2019est l\u00e0 que les solutions propos\u00e9es par Averoa entrent en sc\u00e8ne.<\/p>\n\n\n\n<p>Avec une <strong>approche centr\u00e9e sur le patient<\/strong> (\u00ab&nbsp;human first&nbsp;\u00bb \u00e0 l\u2019image d\u2019Inovall\u00e9e), Averoa s\u2019est donn\u00e9 pour mission d&rsquo;offrir aux patients une prise en charge globale de leurs maladies r\u00e9nales, bas\u00e9e sur des <strong>options th\u00e9rapeutiques efficaces et personnalis\u00e9es<\/strong> soutenues par un <strong>diagnostic pr\u00e9cis<\/strong> et des outils de <strong>pronostic avanc\u00e9s.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2 M\u20ac de fonds lev\u00e9s par Averoa pour acc\u00e9l\u00e9rer les prochaines \u00e9tapes de pr\u00e9paration \u00e0 la mise sur le march\u00e9<\/h3>\n\n\n\n<p>Avec pr\u00e8s 2 millions de fond lev\u00e9s l\u2019\u00e9t\u00e9 dernier, montant son <strong>capital \u00e0 3 millions d\u2019euros<\/strong>, cette startup biotech a plus d\u2019une corde \u00e0 son arc&nbsp;:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Un<strong> pipeline de \u00ab produits d\u00e9risqu\u00e9s \u00bb<\/strong> avec un produit pr\u00eat \u00e0 \u00eatre enregistr\u00e9 en Europe sur les principaux march\u00e9s des maladies r\u00e9nales ;<\/li><li>Un produit en d\u00e9veloppement avec une <strong>d\u00e9signation de m\u00e9dicament orphelin<\/strong> (ODD) accord\u00e9 par l&rsquo;Agence europ\u00e9enne des m\u00e9dicaments (EMA) ;<\/li><li>Une <strong>\u00e9quipe<\/strong> tr\u00e8s exp\u00e9riment\u00e9e avec un <strong>palmar\u00e8s impressionnant de succ\u00e8s<\/strong> dans les strat\u00e9gies de d\u00e9veloppement et d&rsquo;enregistrement r\u00e9glementaire pour les produits innovants ;<\/li><li>Un solide <strong>r\u00e9seau de KOL<\/strong> ;<\/li><li>Un <strong>partenariat industriel <\/strong>en n\u00e9gociation avec un <strong>leader international <\/strong>des maladies r\u00e9nales ;<\/li><li>Une collaboration scientifique avec un <strong>centre de recherche international en biom\u00e9decine<\/strong> ;<\/li><li>De <strong>nouveaux produits<\/strong> \u00e0 fort potentiel commercial pour les maladies chroniques du rein.<\/li><\/ul>\n\n\n\n<p class=\"has-text-align-center has-medium-font-size\"><em>\u00ab&nbsp;Vous ne pouvez pas sauver le monde, mais vous sauverez peut-\u00eatre l\u2019homme qui est en face de vous.&nbsp;\u00bb<\/em> <\/p>\n\n\n\n<p>Cette c\u00e9l\u00e8bre citation d\u2019une infirmi\u00e8re durant la premi\u00e8re guerre mondiale r\u00e9sonne comme un mantra pour Averoa qui est sur le bon chemin pour changer, aujourd\u2019hui et dans les ann\u00e9es \u00e0 venir, la vie de nombreux patients atteints de maladies r\u00e9nales chroniques ou orpheline.<\/p>","protected":false},"excerpt":{"rendered":"<p>Averoa est une startup biotech dont la sp\u00e9cialit\u00e9 est de d\u00e9velopper des solutions th\u00e9rapeutiques pour la prise en charge globale des maladies r\u00e9nales. Ses trois fondateurs, Caroline Roussel Maupetit, Sarah Delbaere et Luc-Andr\u00e9 Granier sont tous les trois riches de plus de 25 ans d\u2019exp\u00e9riences dans le domaine pharmaceutiques des maladies r\u00e9nales, et c\u2019est sur [&hellip;]<\/p>\n","protected":false},"author":37,"featured_media":45010,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45,44],"tags":[],"class_list":["post-44965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-startup-tarmac","category-tarmac-incubator"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments - inovall\u00e9e<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.inovallee.com\/en\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments - inovall\u00e9e\" \/>\n<meta property=\"og:description\" content=\"Averoa est une startup biotech dont la sp\u00e9cialit\u00e9 est de d\u00e9velopper des solutions th\u00e9rapeutiques pour la prise en charge globale des maladies r\u00e9nales. Ses trois fondateurs, Caroline Roussel Maupetit, Sarah Delbaere et Luc-Andr\u00e9 Granier sont tous les trois riches de plus de 25 ans d\u2019exp\u00e9riences dans le domaine pharmaceutiques des maladies r\u00e9nales, et c\u2019est sur [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.inovallee.com\/en\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/\" \/>\n<meta property=\"og:site_name\" content=\"inovall\u00e9e\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/technopoleinovallee\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-14T12:30:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-15T13:47:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Averoa-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1367\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emmanuelle Vouriot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@inovallee\" \/>\n<meta name=\"twitter:site\" content=\"@inovallee\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emmanuelle Vouriot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/\"},\"author\":{\"name\":\"Emmanuelle Vouriot\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#\\\/schema\\\/person\\\/1e7259f9e965ec516d83fdc8ddebbe90\"},\"headline\":\"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments\",\"datePublished\":\"2022-12-14T12:30:55+00:00\",\"dateModified\":\"2022-12-15T13:47:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/\"},\"wordCount\":772,\"publisher\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.inovallee.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Averoa-scaled.jpg\",\"articleSection\":[\"L'\u00e9cho des startups du Tarmac\",\"Tarmac incubator\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/\",\"url\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/\",\"name\":\"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments - inovall\u00e9e\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.inovallee.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Averoa-scaled.jpg\",\"datePublished\":\"2022-12-14T12:30:55+00:00\",\"dateModified\":\"2022-12-15T13:47:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.inovallee.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Averoa-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.inovallee.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Averoa-scaled.jpg\",\"width\":2048,\"height\":1367,\"caption\":\"science pipette with a drop of substance over laboratory test tubes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.inovallee.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#website\",\"url\":\"https:\\\/\\\/www.inovallee.com\\\/\",\"name\":\"inovall\u00e9e technopole, Home to software & smart technologies\",\"description\":\"Home to software &amp; smart technologies\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.inovallee.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#organization\",\"name\":\"inovall\u00e9e\",\"url\":\"https:\\\/\\\/www.inovallee.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.inovallee.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/inovallee_2022_GrenobleAlpes.png\",\"contentUrl\":\"https:\\\/\\\/www.inovallee.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/inovallee_2022_GrenobleAlpes.png\",\"width\":945,\"height\":369,\"caption\":\"inovall\u00e9e\"},\"image\":{\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/technopoleinovallee\\\/\",\"https:\\\/\\\/x.com\\\/inovallee\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/inovall-e\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/inovallee?reload=9\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.inovallee.com\\\/#\\\/schema\\\/person\\\/1e7259f9e965ec516d83fdc8ddebbe90\",\"name\":\"Emmanuelle Vouriot\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments - inovall\u00e9e","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.inovallee.com\/en\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/","og_locale":"en_GB","og_type":"article","og_title":"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments - inovall\u00e9e","og_description":"Averoa est une startup biotech dont la sp\u00e9cialit\u00e9 est de d\u00e9velopper des solutions th\u00e9rapeutiques pour la prise en charge globale des maladies r\u00e9nales. Ses trois fondateurs, Caroline Roussel Maupetit, Sarah Delbaere et Luc-Andr\u00e9 Granier sont tous les trois riches de plus de 25 ans d\u2019exp\u00e9riences dans le domaine pharmaceutiques des maladies r\u00e9nales, et c\u2019est sur [&hellip;]","og_url":"https:\/\/www.inovallee.com\/en\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/","og_site_name":"inovall\u00e9e","article_publisher":"https:\/\/www.facebook.com\/technopoleinovallee\/","article_published_time":"2022-12-14T12:30:55+00:00","article_modified_time":"2022-12-15T13:47:28+00:00","og_image":[{"width":2048,"height":1367,"url":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Averoa-scaled.jpg","type":"image\/jpeg"}],"author":"Emmanuelle Vouriot","twitter_card":"summary_large_image","twitter_creator":"@inovallee","twitter_site":"@inovallee","twitter_misc":{"Written by":"Emmanuelle Vouriot","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#article","isPartOf":{"@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/"},"author":{"name":"Emmanuelle Vouriot","@id":"https:\/\/www.inovallee.com\/#\/schema\/person\/1e7259f9e965ec516d83fdc8ddebbe90"},"headline":"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments","datePublished":"2022-12-14T12:30:55+00:00","dateModified":"2022-12-15T13:47:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/"},"wordCount":772,"publisher":{"@id":"https:\/\/www.inovallee.com\/#organization"},"image":{"@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Averoa-scaled.jpg","articleSection":["L'\u00e9cho des startups du Tarmac","Tarmac incubator"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/","url":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/","name":"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments - inovall\u00e9e","isPartOf":{"@id":"https:\/\/www.inovallee.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Averoa-scaled.jpg","datePublished":"2022-12-14T12:30:55+00:00","dateModified":"2022-12-15T13:47:28+00:00","breadcrumb":{"@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#primaryimage","url":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Averoa-scaled.jpg","contentUrl":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2022\/12\/Averoa-scaled.jpg","width":2048,"height":1367,"caption":"science pipette with a drop of substance over laboratory test tubes"},{"@type":"BreadcrumbList","@id":"https:\/\/www.inovallee.com\/une-revolution-se-prepare-pour-les-maladies-renales-au-sein-daveroa-qui-a-leve-2me-pour-preparer-la-mise-sur-le-marche-de-ses-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.inovallee.com\/"},{"@type":"ListItem","position":2,"name":"Une r\u00e9volution se pr\u00e9pare pour les maladies r\u00e9nales au sein d\u2019Averoa, qui a lev\u00e9 2M\u20ac pour pr\u00e9parer la mise sur le march\u00e9 de ses m\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/www.inovallee.com\/#website","url":"https:\/\/www.inovallee.com\/","name":"inovall\u00e9e technopole, Home to software & smart technologies","description":"Home to software &amp; smart technologies","publisher":{"@id":"https:\/\/www.inovallee.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.inovallee.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.inovallee.com\/#organization","name":"inovall\u00e9e","url":"https:\/\/www.inovallee.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.inovallee.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2023\/08\/inovallee_2022_GrenobleAlpes.png","contentUrl":"https:\/\/www.inovallee.com\/wp-content\/uploads\/2023\/08\/inovallee_2022_GrenobleAlpes.png","width":945,"height":369,"caption":"inovall\u00e9e"},"image":{"@id":"https:\/\/www.inovallee.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/technopoleinovallee\/","https:\/\/x.com\/inovallee","https:\/\/www.linkedin.com\/company\/inovall-e\/","https:\/\/www.youtube.com\/user\/inovallee?reload=9"]},{"@type":"Person","@id":"https:\/\/www.inovallee.com\/#\/schema\/person\/1e7259f9e965ec516d83fdc8ddebbe90","name":"Emmanuelle Vouriot"}]}},"_links":{"self":[{"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/posts\/44965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/comments?post=44965"}],"version-history":[{"count":0,"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/posts\/44965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/media\/45010"}],"wp:attachment":[{"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/media?parent=44965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/categories?post=44965"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.inovallee.com\/en\/wp-json\/wp\/v2\/tags?post=44965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}